About Signal Genetics:

Signal Genetics provides detailed, personalized diagnostic results that can assist cancer patients and their physicians in determining the best course of treatment. Whether you are a patient with cancer or a physician treating cancer patients, contact Signal Genetics for more information today.

Recent News:

1/23/12 — Signal Genetics Announces Publication of Meta-Analysis of its Colon Cancer Test – Previstage™ GCC Confirming Prognostic Capabilities in Patients with Colon Cancer more

12/9/11 — Signal Genetics Announces Launch of Next Generation Genetic Multiple Myeloma Predictive Testing Product – MyPRS Plus™ more

6/29/11 — Signal Genetics and DiagnoCure Announce a US$13.3M Collaboration for the Commercialization of Previstage™ GCC Colorectal Cancer Staging Test more